Medicare Enrolled
Dr. Vita Anksh, M.D.
Endocrinology · Naples, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Anksh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Anksh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Anksh
Dr. Vita Anksh is an endocrinology specialist in Naples, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Anksh performed 44,326 Medicare services across 4,205 unique beneficiaries.
Between the years covered by Open Payments, Dr. Anksh received a total of $21,086 from 62 pharmaceutical and/or device companies across 1225 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Anksh is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in FL
$21,086 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 83804 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗44,326
Medicare services
Top 1% in FL for endocrinology
4,205
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,333 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 26,640 | $18 | $35 |
| Romosozumab injection (Evenity) for osteoporosis | 10,920 | $8 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,955 | $97 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
901 | $67 | $140 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
817 | $46 | $110 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
710 | $40 | $63 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
496 | $60 | $200 |
| Diabetes self-management training, individual Individualized education and training for managing diabetes, billed per 30-minute session. |
432 | $41 | $101 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
329 | $145 | $281 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
252 | $25 | $76 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
195 | $39 | $280 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
190 | $84 | $200 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
165 | $113 | $264 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
163 | $127 | $310 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
125 | $87 | $229 |
| New patient office visit, complex (60-74 min) | 36 | $178 | $382 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$21,086
Total received (2018-2024)
Avg $3,012/year across 7 years
Top 18% in FL for endocrinology
62
Companies
1,225
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,086 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,670
2023
$3,725
2022
$2,697
2021
$2,667
2020
$2,962
2019
$3,031
2018
$3,333
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
SANOFI-AVENTIS U.S. LLC
$2,042
Lilly USA, LLC
$1,990
Novo Nordisk Inc
$1,761
Amgen Inc.
$1,726
AstraZeneca Pharmaceuticals LP
$1,399
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,155
Insulet Corporation
$1,015
Xeris Pharmaceuticals, Inc.
$921
MannKind Corporation
$829
Radius Health, Inc.
$573
Mannkind Corporation
$557
Novartis Pharmaceuticals Corporation
$480
IBSA Pharma Inc.
$478
Corcept Therapeutics
$457
Merck Sharp & Dohme Corporation
$405
Dexcom, Inc.
$394
Janssen Pharmaceuticals, Inc
$359
Tandem Diabetes Care, Inc.
$332
Amneal Pharmaceuticals LLC
$306
Abbott Laboratories
$277
Nevro Corp.
$276
Bayer Healthcare Pharmaceuticals Inc.
$257
Alexion Pharmaceuticals, Inc.
$249
RECORDATI_RARE_DISEASES_INC.
$242
Esperion Therapeutics, Inc.
$222
Kowa Pharmaceuticals America, Inc.
$189
Bayer HealthCare Pharmaceuticals Inc.
$183
Amarin Pharma Inc.
$171
AbbVie, Inc.
$149
ABBVIE INC.
$142
DEXCOM, INC.
$121
Zealand Pharma US, Inc.
$96
AbbVie Inc.
$88
Ultragenyx Pharmaceutical Inc.
$87
Valeritas, Inc.
$83
Horizon Therapeutics plc
$81
Amryt Pharma Holdings Ltd
$81
Companion Medical, Inc.
$75
Antares Pharma, Inc.
$72
OPKO Pharmaceuticals, LLC
$67
VIVUS, Inc.
$65
Regeneron Healthcare Solutions, Inc.
$58
Almatica Pharma LLC
$57
KVK-Tech, Inc.
$55
EUSA Pharma (US) LLC
$46
VIVUS LLC
$45
Alvogen Inc
$34
Sandoz Inc.
$28
Currax Pharmaceuticals LLC
$28
Becton, Dickinson and Company
$27
Nestle HealthCare Nutrition Inc.
$27
BETA BIONICS, INC.
$27
Kyowa Kirin, Inc.
$26
Allergan, Inc.
$25
GRT US Holding, Inc.
$24
Allergan Inc.
$23
Medtronic, Inc.
$21
Medtronic MiniMed, Inc.
$20
Amphastar Pharmaceuticals, Inc.
$17
Ascensia Diabetes Care Us Inc.
$16
CeQur Corporation
$15
Senseonics, Incorporated
$14
Top 3 companies account for 27.5% of total payments
Associated products mentioned in payments ›
ADMELOG · AFREZZA · Androgel · BAQSIMI · BD Nano · BYDUREON · CONTRAVE · CRYSVITA · CeQur Simplicity · Crysvita · Cryvista · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · EVERSENSE E3 SMART TRANSMITTER KIT · EVKEEZA · Eversense · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · HUMULIN U · INTELLIS ADAPTIVESTIM · INVOKANA · ISTURISA · InPen · JANUMET · JANUVIA · JARDIANCE · KEVEYIS · Kerendia · Korlym · LEQVIO · LICART · LINZESS · LOKELMA · Licart · Livalo · MOUNJARO · MYALEPT · MYCAPSSA · NEXLETOL · NO PRODUCT DISCUSSED · NOCDURNA · Omnipod · Ozempic · PANCREAZE · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · QSYMIA · Qutenza · RAYALDEE · RAYOS · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Senza · Strensiq · Sylvant · Synthroid · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UBRELVY · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZENPEP · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $48 per 100 Medicare services performed
Geographic Context
Endocrinologists within 10 mi
18
Per 100K population
4.6
County median income
$86,173
Nearest hospital
PHYSICIANS REGIONAL MEDICAL CENTER - PINE RIDGE
3.3 mi
3.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Anksh is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), with low-engagement industry engagement in the top 18% of FL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Anksh experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Anksh performed 26,640 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Anksh receive payments from pharmaceutical companies?
Yes. Dr. Anksh received a total of $21,086 from 62 companies across 1,225 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Anksh's costs compare to other endocrinologists in Naples?
Dr. Anksh's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Anksh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Naples
Browse endocrinologists in Naples ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in FL
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in FL
Which FL endocrinologists receive the most from drug and device companies.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology